QUOTE AND NEWS
StreetInsider.com  Nov 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vical+%28VICL%29+Misses+Q3+EPS+by+1c%3B+Revenues+Above+Consensus/5072578.html for the full story.
StreetInsider.com  Oct 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vical+%28VICL%29+Reports+Publication+of+Two+Articles+About+Vaxfectin/5042519.html for the full story.
StreetInsider.com  Oct 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vical%27s+%28VICL%29+TransVax+CMV+Vaccine+Celluar+Immune+Responses+Increased+Over+Placebo+in+Phase+2/5000276.html for the full story.
MarketWatch  Oct 1  Comment 
Vical Inc. said Thursday that the U.S. Navy has awarded a contract for $1.25 million to support large-scale vaccine manufacturing and related clinical and regulatory preparations for a Phase 1 clinical trial of the company's swine flu vaccine....
StreetInsider.com  Sep 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Vical+%28VICL%29+Licensee+Sanofi-aventis+Completes+Enrollment+in+Phase+3+Angiogenesis+Trial/4973449.html for the full story.
MarketWatch  Sep 24  Comment 
Vical rose 12% in premarket trade after it said animal studies showed a cancer vaccine with the company's Vaxfection extra ingredient proved effective. Vical said the data encourage further development of additional cancer applications and...
StreetInsider.com  Sep 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vical+%28VICL%29+Pandemic+Influenza+Vaccine+Demonstrates+Cross-reactivity+Against+California%2C+Texas+and+Mexico+H1N1+Strains/4933791.html for the full story.
Contrarian Profits  Sep 9  Comment 
Biopharma Vical (NASDAQ:VICL) has risen to its highest share price in a year — and with rumors of a buyout offer, it shows no sign of stopping. The share price for Vical Incorporated (NASDAQ:VICL) jumped over 15% earlier this month on the...
StreetInsider.com  Sep 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Vical+%28VICL%29+Announces+%242.5M+Payment+for+Funding+of+Allovectin-7+Phase+3+Trial/4925508.html for the full story.
Contrarian Profits  Aug 26  Comment 
Pre-pandemic profits on Sinovac (AMEX:SVA) Vical Incorporated (NASDAQ:VICL), and Dr. Reddy’s Laboratories (NYSE:RDY)? Six days ago, on Aug. 20, I sent out our TFN Special Report: The Top Swine Flu Vaccine Stocks under $20. You know the kind of...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


You may also be interested in articles related to Vical (VICL):
 
VICL AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki